When should a rapid influenza antigen (influenza card) test be performed and how should the results be managed?

Rapid Influenza Antigen Testing: When to Test and How to Manage Results

Perform rapid influenza antigen (card) tests in outpatients within 12-48 hours of symptom onset using nasopharyngeal swabs, but recognize that a positive result confirms influenza while a negative result does not rule it out—particularly in hospitalized patients where molecular testing (RT-PCR) should be used instead. 1

When to Perform the Test

Timing is Critical

• Collect specimens within 4 days of symptom onset, preferably within 12-48 hours 1, 2
• Testing before 12 hours after symptom onset significantly reduces sensitivity—29% of patients tested within 12 hours who were initially negative became positive when retested after 12 hours 2
• Sensitivity peaks at 97.1% when testing occurs within 48 hours of illness onset 3
• After 12 hours but within 48 hours remains the optimal window for accurate diagnosis 2

Specimen Collection Priority (in order of preference)

1. Nasopharyngeal swabs (first choice) 1
2. Mid-turbinate nasal swabs (second choice) 1
3. Combined nasal-throat swabs (if nasopharyngeal unavailable) 1
4. Use flocked swabs over non-flocked swabs 1

Common Pitfall: Throat swabs alone have poor sensitivity—avoid using them as single specimens 1

Who Should Be Tested

Outpatients (Where RIDTs Are Appropriate)

• Patients presenting with influenza-like illness during epidemic season 1
• RIDTs are conditionally recommended for outpatients to improve detection 1
• The test performs best in patients at 12-48 hours post-symptom onset 3, 2

Hospitalized Patients (Where RIDTs Should NOT Be Used)

• Do not use rapid antigen tests in hospitalized patients except when molecular assays are unavailable 1
• Use RT-PCR or other molecular assays as the primary test 1
• If an RIDT is performed and negative, mandatory follow-up with RT-PCR is required 1

How to Interpret Results

Positive RIDT Result

• High specificity (89-99%): A positive result firmly confirms influenza diagnosis 3, 4
• Proceed with antiviral treatment if clinically indicated
• No confirmatory testing needed in outpatients

Negative RIDT Result

• Limited sensitivity (58.9-77%): A negative result does NOT exclude influenza 4, 5
• Consider clinical context: high fever and chills suggest influenza despite negative test 4
• In hospitalized patients: Mandatory RT-PCR confirmation of negative results 1
• In outpatients during epidemic season:
  • If tested before 12 hours: Consider repeat testing after 12 hours 2
  • If high clinical suspicion persists: Consider molecular testing or empiric treatment based on clinical judgment

Test Performance Limitations

The sensitivity varies significantly by:

• Timing: 29% false negative rate if tested within 12 hours 2
• Specimen type: Nasopharyngeal swabs show 58.9% sensitivity vs. only 10.3% for oropharyngeal swabs 5
• Viral load: Detection decreases at lower virus concentrations 6
• Influenza type: Better sensitivity for Influenza A (90%) than Influenza B (25%) 7

Clinical Algorithm

For Outpatients:

1. If >12 hours but <48 hours from symptom onset → Perform RIDT with nasopharyngeal swab
2. Positive result → Treat as influenza
3. Negative result + high clinical suspicion → Consider molecular testing or treat empirically based on epidemic activity and risk factors

For Hospitalized Patients:

1. Skip RIDTs entirely → Proceed directly to RT-PCR 1
2. If RIDT performed and negative → Mandatory RT-PCR confirmation 1

Avoid Testing:

• Non-respiratory sites (blood, CSF, urine, stool) 1
• Serological testing for acute management 1